Mallinckrodt Pharmaceuticals is an innovation-driven specialty pharmaceutical company focused on improving outcomes for patients with severe and critical conditions. Among the company’s most innovative areas of focus is regenerative medicine – cell therapy – and […]
Mallinckrodt earned recent recognition as a Frost & Sullivan Manufacturing Leadership Award winner for its outstanding achievement in three categories – Operational Excellence Leadership, Supply Chain Leadership and Sustainability Leadership, as covered previously when the […]
Mallinckrodt announced today that its Global External Manufacturing Operations site in College Business & Technology Park, Dublin, Ireland, has been awarded certification to the international standard for Information Security Management (ISO 27001). This international standard […]
The Canadian College of Health Leaders (CCHL) has named Mallinckrodt Pharmaceuticals as the 2018 recipient of the President’s Award for Outstanding Corporate Membership in the College. The award was given to the company at the […]